SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Skin & hair

Fading Hyperpigmentation on Darker Skin: What Works and What to Avoid

Post-inflammatory hyperpigmentation — dark marks left after acne, rashes, or skin injury — is especially common in Fitzpatrick skin types IV–VI because melanocytes in deeper skin tones are more reactive. With proven topical ingredients, daily sunscreen, and avoidance of irritating treatments, these marks fade significantly faster than they would on their own.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

Why Does Darker Skin Get More Noticeable Dark Marks?

Skin color comes from melanin produced by melanocytes. People with deeper skin tones do not have more melanocytes than those with lighter skin — they have melanocytes that produce more and larger melanin packages, and those cells are considerably more reactive to triggers such as inflammation, UV exposure, or physical injury 1.

This means even minor irritation — a pimple, a bug bite, friction from tight clothing — can deposit a burst of excess pigment that takes months to fade. This reactivity is a characteristic of deeply pigmented skin, not a flaw. Epidermal PIH (in the upper skin layer) tends to be brown and improves over six to twelve months; dermal PIH (deeper, blue-gray in tone) can be more persistent 2.

Treatments work by slowing melanin overproduction and allowing natural skin-cell turnover to carry the excess pigment to the surface where it sheds. Consistent sun protection prevents UV from deepening marks while treatment is in progress.

Which Topical Ingredients Have the Best Evidence for PIH in Deeper Skin?

A 2024 systematic review of 48 studies covering more than 1,300 people with skin of color found that topical retinoids produced partial improvement in about 85% of participants — the highest rate of any modality tested 1. Several other well-studied ingredients round out a layered approach:

Niacinamide (vitamin B3) reduces the transfer of melanin from melanocytes to surrounding keratinocytes and has anti-inflammatory properties that help prevent new PIH from forming 3. It is generally well tolerated and a reasonable starting point for daily use.

Azelaic acid inhibits tyrosinase (an enzyme central to melanin production) and has an antiproliferative effect specifically on abnormal melanocytes, making it useful when acne is an ongoing contributor to PIH 4. It carries Grade A recommendation in a systematic review of melasma and hyperpigmentation therapies 5.

Kojic acid is a fungus-derived compound that chelates divalent ions and inhibits tyrosinase. In head-to-head comparisons in Fitzpatrick IV–V skin, formulations containing kojic acid demonstrated meaningful pigment reduction 4.

Tranexamic acid (topical) inhibits melanogenesis through anti-plasmin and anti-tyrosinase mechanisms and has been shown in clinical trials to reduce PIH and melasma indices; an updated 2024 review confirmed efficacy across PIH, rosacea, and post-acne erythema with a favorable safety profile 6.

Vitamin C (L-ascorbic acid) inhibits tyrosinase by interacting with copper ions at the active site, and a Bayesian meta-analysis of 31 randomized controlled studies found topical vitamin C at concentrations of 3–10% reduced UV-induced pigmentation with a good safety profile. Stability varies considerably across formulations — look for stabilized or encapsulated forms.

Topical retinoids (over-the-counter retinol or prescription tretinoin) accelerate cell turnover so that dark marks shed more quickly 7. Because retinoids can cause initial irritation — which can itself trigger new PIH in reactive skin — a low-concentration, gradual introduction matters greatly.

Sunscreen underpins all of these. A 2023 British Journal of Dermatology review found that UV and even visible-light exposure induces and augments pigmentary disorders in skin of color, and recommended minimum SPF 30 broad-spectrum coverage alongside depigmenting agents for patients with hyperpigmentation 8. Without it, every treatment is working against an active photostimulation of melanocytes.

Does Sunscreen Actually Matter for Darker Skin?

Yes — and it is often under-emphasized. Natural melanin provides some baseline UV protection (roughly equivalent to SPF 13 in deeply pigmented skin), but this does not meaningfully blunt the UV stimulus that deepens and prolongs PIH. UV exposure, particularly UVA which penetrates to the melanocyte-rich dermis, continues to drive pigment overproduction even during topical treatment 8.

A randomized trial found that a broad-spectrum sunscreen containing niacinamide and sclareolide reduced the incidence of post-inflammatory hyperpigmentation in skin of color compared with control — suggesting sunscreen formulated with active depigmenting agents may offer additive benefit 9.

The historic concern — that mineral sunscreens (zinc oxide, titanium dioxide) leave a visible white cast on deeper skin — is real but addressable. Tinted mineral formulations and iron-oxide-containing sunscreens match diverse skin tones and also filter visible light, which is clinically relevant for melasma and PIH 8. A daily habit of SPF 30 or higher applied every morning, including cloudy days and near windows, is not optional — it is the treatment foundation.

What Is Melasma, and How Is It Different from PIH?

Melasma and PIH are frequently confused but have distinct patterns, triggers, and treatment nuances.

PIH appears at the exact site of a prior skin event (a pimple, scratch, eczema flare) and is typically asymmetric. Melasma produces symmetric brown or gray-brown patches, most commonly across the cheekbones, bridge of the nose, forehead, and upper lip. It is strongly hormone-associated: it affects an estimated 14–56% of pregnant women and 11–46% of oral contraceptive users 10.

The mechanism is different: in melasma, estrogen and progesterone directly stimulate melanogenic enzymes (tyrosinase, Tyrp1, Tyrp2), and melanocytes in affected areas show increased expression of sex hormone receptors 10. This is why melasma can recur or worsen with hormonal contraception, pregnancy, or sun exposure even after successful treatment, and why a clinician evaluating melasma may consider whether a change in contraception is part of the plan.

Many of the same topical agents (azelaic acid, niacinamide, tranexamic acid, kojic acid) are used for both conditions, but the sustained hormonal and UV triggers in melasma mean that treatment duration is longer and relapses are common 5.

What Should I Be Cautious About?

Not every treatment marketed for dark spots is safe for melanin-rich skin:

Chemical peels at high concentrations, particularly in inexperienced hands, carry real risk of post-peel PIH that is worse than the original marks. Glycolic acid and similar AHAs at lower concentrations used consistently can promote turnover, but the benefit-to-risk calculation shifts as concentration rises 2.

Laser and light therapy produced partial improvement in about 66% of participants in the 2024 systematic review, but also caused exacerbation in a meaningful subset 1. Certain devices — particularly ablative lasers and some intense pulsed light (IPL) systems — carry significant burn and re-pigmentation risk in Fitzpatrick IV–VI skin. A provider experienced specifically with darker skin tones and using equipment appropriate for your Fitzpatrick type is important before any in-office procedure.

Hydroquinone has been an effective prescription brightening agent for decades, but the FDA has determined that OTC skin lightening products containing hydroquinone are not generally recognized as safe and effective; OTC hydroquinone is effectively prohibited from US store shelves. It remains available through prescription under dermatologist supervision. Extended use without supervision carries risks including ochronosis (blue-gray permanent skin discoloration).

Imported or unlabeled skin-lightening creams are a serious concern. FDA laboratory testing has found numerous such products with mercury and/or undisclosed hydroquinone; mercury is not listed on labels but can be absorbed through the skin, causing nervous system, kidney, and immune damage. The FDA has issued warnings and product-specific alerts — if a skin-lightening product comes without a recognized brand label, came from abroad, or is unusually inexpensive, do not use it.

When Is It Time to See a Dermatologist?

Many people make meaningful progress with OTC options before seeking care. A dermatologist becomes especially valuable when:

  • OTC treatments have not produced visible improvement after three to four months of consistent daily use
  • The pattern suggests melasma (symmetric, UV-worsened, hormone-linked) rather than straightforward PIH
  • Acne is ongoing and creating new marks faster than existing ones can fade — treating the source is as important as fading existing marks
  • You want to discuss prescription options (tretinoin, prescription azelaic acid, supervised hydroquinone) or combination regimens
  • You are considering a professional peel or laser procedure and want to confirm the treatment protocol is appropriate for your Fitzpatrick type
  • Any spot is raised, has irregular borders, is changing in size or color, or bleeds — these features warrant evaluation to rule out a skin lesion

When seeking a dermatologist, it is reasonable to ask directly whether they have experience treating patients with Fitzpatrick types IV–VI. Decisions about laser selection and peel concentration carry different risk profiles for deeper skin, and provider experience matters meaningfully.

Common questions

How long does post-inflammatory hyperpigmentation take to fade?

Epidermal PIH (brown marks in the upper skin layer) typically fades over six to twelve months with consistent sunscreen use and topical treatment. Dermal PIH (darker, blue-gray marks in deeper layers) can be more persistent and may take longer. Treatment does not erase marks overnight — visible fading over weeks to months is the expected pace.

Can niacinamide and azelaic acid be used together?

Yes. They work through different mechanisms — niacinamide reduces melanin transfer; azelaic acid inhibits melanin production at the melanocyte — and are generally well tolerated together. Combination approaches targeting multiple steps in the pigmentation pathway are commonly used for PIH. Introduce one ingredient at a time so that if irritation occurs, you know which product is responsible.

Is it safe to use retinoids on deeper skin tones?

Retinoids are among the most evidence-supported tools for PIH in skin of color, but they require a careful introduction. Because retinoids cause initial peeling and irritation — and irritation itself triggers new PIH in reactive skin — starting with a low concentration (retinol 0.025–0.05%, or prescription tretinoin at the lowest available strength) applied two to three nights per week and building up slowly is standard practice. A dermatologist can guide the right entry point for your skin.

Do skin-lightening products from abroad work better?

Products marketed from abroad — particularly those claiming dramatic or rapid results — carry real safety risk. FDA testing has found numerous such products containing mercury or undisclosed hydroquinone, neither of which is on the label. Mercury absorbs through the skin and can cause serious and potentially permanent neurological and kidney damage. A product that is effective and safe will list its active ingredients clearly.

Is sunscreen really necessary if I already have darker skin?

Yes. Although melanin provides some baseline UV protection, it does not adequately block the UV and visible-light stimulus that deepens and prolongs PIH. UV exposure — including through windows and on cloudy days — is the primary driver of ongoing pigment overproduction. Broad-spectrum SPF 30 or higher applied every morning is not a supplement to treatment; it is a core component of it.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

When to seek evaluation

  • —A dark spot or patch that is raised, has irregular borders, has changed in size or color, or bleeds — have this evaluated by a dermatologist to rule out a skin lesion before treating it as PIH
  • —Brown or gray symmetric patches across the cheekbones, forehead, or upper lip that are persistent or worsening — this pattern may suggest melasma, which has different treatment considerations
  • —Any skin lightening product without a clear label, purchased from abroad, or unusually inexpensive — some contain mercury or undisclosed high-dose hydroquinone that can cause serious, potentially permanent harm
  • —Signs of mercury exposure from a skin product: tremor, memory problems, numbness, or kidney symptoms — stop use immediately and contact a clinician

This article is general educational information and does not constitute a diagnosis or personalized skincare regimen. Consult a licensed dermatologist experienced with deeper skin tones before beginning prescription treatments or professional procedures.

References

  1. 1.Mar K, Khalid B, Maazi M, Ahmed R, Wang OJE, Khosravi-Hafshejani T (2024). Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review. Journal of Cutaneous Medicine and Surgery. doi:10.1177/12034754241265716 ✓Systematic review of 48 studies, 1356 individuals with skin of color; topical retinoids produced partial improvement in 85% of participants; laser therapy partial improvement in 66% with exacerbation risk; overall lack of robust efficacy across all modalities
  2. 2.Lawrence E, Syed HA, Al Aboud KM (2024). Postinflammatory Hyperpigmentation. StatPearls (NCBI Bookshelf). link ✓Epidermal PIH (brown) improves within 6–12 months; dermal PIH (blue-gray) potentially permanent; incidence up to 65% in acne; triggers include acne, atopic dermatitis, infections, procedures
  3. 3.Boo YC (2021). Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants (Basel). doi:10.3390/antiox10081315 ✓Niacinamide reduces melanin transfer from melanocytes to keratinocytes; anti-inflammatory properties support use in PIH
  4. 4.Liyanage A, Liyanage G, Sirimanna G, Schürer N (2022). Comparative Study on Depigmenting Agents in Skin of Color. Journal of Clinical and Aesthetic Dermatology. PMID 35309879 ✓Azelaic acid and kojic acid formulations showed significant pigment reduction in Fitzpatrick IV–V skin; arbutin showed notable efficacy in controlled comparison
  5. 5.Sarkar R, Handog EB, Das A, Bansal A (2023). Topical and Systemic Therapies in Melasma: A Systematic Review. Indian Dermatology Online Journal. doi:10.4103/idoj.idoj_490_22 ✓Azelaic acid and kojic acid carry Grade A recommendation; oral tranexamic acid has strong recommendation; treatment should be individualized
  6. 6.Chen T, Xue J, Wang Q (2024). Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update. Clinical, Cosmetic and Investigational Dermatology. doi:10.2147/CCID.S479411 ✓Tranexamic acid reduces melanogenesis via anti-plasmin and anti-tyrosinase mechanisms; effective for PIH, post-acne erythema; favorable safety profile across oral, topical, and intradermal routes
  7. 7.Sitohang IBS, Makes WI, Sandora N, Suryanegara J (2022). Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. International Journal of Women's Dermatology. doi:10.1097/JW9.0000000000000003 ✓Topical retinoids accelerate epidermal cell turnover, supporting use for dark mark reduction; initial irritation risk in reactive skin requires gradual introduction
  8. 8.Krutmann J, Piquero-Casals J, Morgado-Carrasco D, Granger C, Trullàs C, Passeron T, Lim HW (2023). Photoprotection for people with skin of colour: needs and strategies. British Journal of Dermatology. doi:10.1093/bjd/ljac046 ✓UV and visible light induce and augment pigmentary disorders in skin of color; minimum SPF 30 broad-spectrum coverage recommended; tinted sunscreens with iron oxide filter visible light relevant for PIH and melasma
  9. 9.Passeron T, Brown A, Furmanczyk M, Foyaca M, Trullas C, Piquero-Casals J (2026). An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen Containing Sclareolide and Niacinamide for the Prevention of Post-inflammatory Hyperpigmentation in Skin of Color. Dermatology and Therapy. doi:10.1007/s13555-025-01586-w ✓Randomized trial: broad-spectrum sunscreen with niacinamide and sclareolide reduced PIH incidence in skin of color versus control
  10. 10.Liu W, Chen Q, Xia Y (2023). New Mechanistic Insights of Melasma. Clinical and Cosmetic Investigational Dermatology. doi:10.2147/CCID.S396272 ✓Estrogen and progesterone stimulate melanogenic enzymes in melasma; melanocytes in melasma lesions show increased sex hormone receptor expression; melasma affects 14–56% of pregnant women and 11–46% of OCP users

10 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.